195 related articles for article (PubMed ID: 31322613)
1. GATA2 Deficiency: Early Identification for Improved Clinical Outcomes.
Cole K; Avila D; Parta M; Schuver B; Holland S; Shah N; Hickstein D
Clin J Oncol Nurs; 2019 Aug; 23(4):417-422. PubMed ID: 31322613
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
[TBL] [Abstract][Full Text] [Related]
3. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
4. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
5. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
7. Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS.
Saida S; Umeda K; Yasumi T; Matsumoto A; Kato I; Hiramatsu H; Ohara O; Heike T; Adachi S
Pediatr Transplant; 2016 Mar; 20(2):333-6. PubMed ID: 26748574
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of GATA2-related myeloid neoplasms.
Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
[TBL] [Abstract][Full Text] [Related]
10. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.
Cuellar-Rodriguez J; Gea-Banacloche J; Freeman AF; Hsu AP; Zerbe CS; Calvo KR; Wilder J; Kurlander R; Olivier KN; Holland SM; Hickstein DD
Blood; 2011 Sep; 118(13):3715-20. PubMed ID: 21816832
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of GATA2 deficiency syndrome.
Calvo KR; Hickstein DD
Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
[TBL] [Abstract][Full Text] [Related]
12. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
[TBL] [Abstract][Full Text] [Related]
13. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
14. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract][Full Text] [Related]
15. Successful Myeloablative Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in a Young Girl With GATA2 Deficiency and Emberger Syndrome.
Ramzan M; Lowry J; Courtney S; Krueger J; Schechter Finkelstein T; Ali M
J Pediatr Hematol Oncol; 2017 Apr; 39(3):230-232. PubMed ID: 28234738
[TBL] [Abstract][Full Text] [Related]
16. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
18. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report.
Mendes-de-Almeida DP; Andrade FG; Borges G; Dos Santos-Bueno FV; Vieira IF; da Rocha LKMDS; Mendes-da-Cruz DA; Zancopé-Oliveira RM; Calado RT; Pombo-de-Oliveira MS
BMC Med Genet; 2019 Apr; 20(1):64. PubMed ID: 31035956
[TBL] [Abstract][Full Text] [Related]
19. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
